One-Person trial tests psoriasis pill on nails
NCT ID NCT05124080
First seen Jan 10, 2026 · Last updated May 16, 2026 · Updated 29 times
Summary
This early-stage study tested an oral medication called deucravacitinib for nail psoriasis in one adult participant. The goal was to see if the drug could improve nail appearance and reduce severity over 48 weeks. The study was completed but only enrolled one person, so results are very limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAIL PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Alabama at Birmingham - Department of Dermatology
Birmingham, Alabama, 35233, United States
Conditions
Explore the condition pages connected to this study.